M. Durand

发表

Identifying COVID-19 phenotypes using cluster analysis and assessing their clinical outcomes

C. Chartrand-Lefebvre, E. Montagnon, M. Chassé, 2022, medRxiv.

T Cell Immunogenicity, Gene Expression Profile, and Safety of Four Heterologous Prime-Boost Combinations of HIV Vaccine Candidates in Healthy Volunteers: Results of the Randomized Multi-Arm Phase I/II ANRS VRI01 Trial

B. Hejblum, F. Lucht, J. Lelièvre, 2022, The Journal of Immunology.

Long-lasting severe immune dysfunction in Ebola virus disease survivors

C. Levy-marchal, E. Delaporte, B. Hejblum, 2019, Nature Communications.

CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death

G. Pantaleo, Y. Yazdanpanah, J. Timsit, 2021, iScience.

CD177, a specific marker of neutrophil activation, is a hallmark of COVID-19 severity and death

G. Pantaleo, Y. Yazdanpanah, J. Timsit, 2020, medRxiv.

CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death

Y. Yazdanpanah, J. Timsit, L. Bouadma, 2022, iScience.

Sustained IFN signaling is associated with delayed development of SARS-CoV-2-specific immunity

D. Vézina, D. Kaufmann, E. Bareke, 2023, medRxiv.

Identification of early gene expression profiles associated with long-lasting antibody responses to the Ebola vaccine Ad26.ZEBOV/MVA-BN-Filo.

B. Hejblum, R. Thiébaut, L. Richert, 2023, Cell reports.